FIGURE

Fig. 4

ID
ZDB-FIG-260414-9
Publication
Wirth et al., 2026 - SMN1 variants identified by false-positive SMA newborn screening tests: Therapeutic hurdles and functional and epidemiological solutions
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4

SMN1-861VUS transgene fully complements the loss of SMN function in zebrafish (A) DNA transgene Tg(UBI-mKate_SMN1-861VUS) integrated into the genome of zebrafish mutants smn1Y262stop−/+. (B) Representative images showing morphology from 2 to 25 days post-fertilization (dpf). Homozygous smn1Y262stop−/− mutants exhibit progressive deterioration and premature death between 5 and 6 dpf, while expression of Tg(UBI-mKate2-SMN1-861VUS) restores normal development, morphology, and survival. Scale bar: 1,000 μm. (C) Growth curves showing larval length measurements (±SEM) from 2 to 20 dpf. No significant difference was observed between wild-type (WT), heterozygous, and Tg(UBI-mKate_SMN1-861VUS)-complemented smn1Y262stop−/− animals. The inset (bottom right) highlights comparable body size at 18 dpf. (D) Motor function comparison from 5 to 20 dpf. Total distance swam (±SEM) during a 24-min recording. Homozygous smn1Y262stop−/− mutants display rapid motor function loss culminating in near paralysis by 5 dpf, whereas the transgene Tg(UBI-mKate_SMN1-861VUS) restores normal locomotor activity indistinguishable from WT and heterozygous controls. Data were analyzed using a non-parametric Kruskal-Wallis test, followed by Dunn’s post hoc correction for multiple comparisons; ∗∗∗∗p < 0.0001.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Observed In:
Stage Range: Day 5 to Days 14-20

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Am. J. Hum. Genet.